Current guidelines recommend a genetic analysis of only five genes (KCNH2, KCNQ1, KCNJ2, CACNA1C, and CACNB2b) in all clinically diagnosed or suspected SQTS cases due to high lethality (13). This evidence concerns the gene KCNJ2 and Familial short QT syndrome.